# FDA Inspection 1251327 - Eisai Pharmaceuticals India Pvt. Ltd. - August 30, 2024

Source: https://www.keypedia.com/records/fda_inspections/eisai-pharmaceuticals-india-pvt-ltd/4644c3a0-12ec-4bb5-aa5c-235c8eede1b3
Source feed: FDA_Inspections

> FDA Inspection 1251327 for Eisai Pharmaceuticals India Pvt. Ltd. on August 30, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1251327
- Company Name: Eisai Pharmaceuticals India Pvt. Ltd.
- Inspection Date: 2024-08-30
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 990459 - 2016-10-14](https://www.keypedia.com/records/fda_inspections/eisai-pharmaceuticals-india-pvt-ltd/c2394080-98c3-4c84-a05f-d109c6bc2c1e)
- [FDA Inspection 761022 - 2011-10-21](https://www.keypedia.com/records/fda_inspections/eisai-pharmaceuticals-india-pvt-ltd/51fc47e7-e252-4704-9a39-d722116afb92)

Company: https://www.keypedia.com/companies/eisai-pharmaceuticals-india-pvt-ltd/3622baa1-510c-408a-b6cf-4bf87fa4b4ca

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c